These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 19908326

  • 1. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy.
    Kobylecki C, Silverdale MA, Varma A, Dick JP, Kellett MW.
    Mov Disord; 2009 Dec 15; 24(16):2441-2. PubMed ID: 19908326
    [No Abstract] [Full Text] [Related]

  • 2. Levodopa-responsive parkinsonism in probable extrapontine myelinolysis of the mesencephalon.
    Toft M, Dietrichs E.
    Mov Disord; 2011 Oct 15; 26(12):2180-1. PubMed ID: 22021157
    [No Abstract] [Full Text] [Related]

  • 3. Levodopa-responsive posttraumatic parkinsonism is not associated with changes of echogenicity of the substantia nigra.
    Kivi A, Trottenberg T, Kupsch A, Plotkin M, Felix R, Niehaus L.
    Mov Disord; 2005 Feb 15; 20(2):258-60. PubMed ID: 15551348
    [No Abstract] [Full Text] [Related]

  • 4. Parkinsonism following anterior choroidal artery stroke.
    Sibon I, Guyot M, Allard M, Tison F.
    Eur J Neurol; 2004 Apr 15; 11(4):283-4. PubMed ID: 15061831
    [No Abstract] [Full Text] [Related]

  • 5. Choreiform dyskinesias following levodopa treatment of parkinsonism due to osmotic demyelination syndrome.
    de Souza A, de Souza RJ.
    Parkinsonism Relat Disord; 2017 Oct 15; 43():120-121. PubMed ID: 28729089
    [No Abstract] [Full Text] [Related]

  • 6. Should 3,4-dihydroxy-L-phenylalanine be used routinely in vascular Parkinson?
    Lauretani F, Maggio M, Nardelli A, Saccavini M, Ceda G.
    J Am Geriatr Soc; 2008 Oct 15; 56(10):1977-8. PubMed ID: 19054214
    [No Abstract] [Full Text] [Related]

  • 7. Dopa-responsive hemiparkinsonism due to midbrain Virchow-Robin spaces?
    Krause M, Hähnel S, Haberkorn U, Meinck HM.
    J Neurol; 2005 Dec 15; 252(12):1555-7. PubMed ID: 16284714
    [No Abstract] [Full Text] [Related]

  • 8. Hemiparkinsonism and levodopa-induced dyskinesias after focal nigral lesion.
    Růzicka E, Urgosík D, Jech R, Roth J, Vymazal J, Mecír P, Vladyka V.
    Mov Disord; 2005 Jun 15; 20(6):759-62. PubMed ID: 15782419
    [Abstract] [Full Text] [Related]

  • 9. Novel compound heterozygous synaptojanin-1 mutation causes l-dopa-responsive dystonia-parkinsonism syndrome.
    Rauschendorf MA, Jost M, Stock F, Zimmer A, Rösler B, Rijntjes M, Piroth T, Coenen VA, Reinacher PC, Meyer PT, Frings L, Weiller C, Fischer J, Klebe S.
    Mov Disord; 2017 Mar 15; 32(3):478-480. PubMed ID: 27869329
    [No Abstract] [Full Text] [Related]

  • 10. Dopa-responsive parkinsonism after acute subdural hematoma.
    Maertens de Noordhout A, Daenen F, Bex V.
    Eur J Neurol; 2006 Jul 15; 13(7):e10-1. PubMed ID: 16834685
    [No Abstract] [Full Text] [Related]

  • 11. Hemiparkinsonism with a discrete lacunar infarction in the contralateral substantia nigra.
    Ohta K, Obara K.
    Mov Disord; 2006 Jan 15; 21(1):124-5. PubMed ID: 16229001
    [No Abstract] [Full Text] [Related]

  • 12. The relationship between cerebral vascular disease and parkinsonism: The VADO study.
    Antonini A, Vitale C, Barone P, Cilia R, Righini A, Bonuccelli U, Abbruzzese G, Ramat S, Petrone A, Quatrale R, Marconi R, Ceravolo R, Stefani A, Lopiano L, Zappia M, Capus L, Morgante L, Tamma F, Tinazzi M, Colosimo C, Guerra UP.
    Parkinsonism Relat Disord; 2012 Jul 15; 18(6):775-80. PubMed ID: 22531611
    [Abstract] [Full Text] [Related]

  • 13. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism.
    Pita Lobo P, Coelho M, Mestre TA, Rosa MM, Ferreira JJ.
    Mov Disord; 2013 Aug 15; 28(9):1212-4. PubMed ID: 23861327
    [No Abstract] [Full Text] [Related]

  • 14. [Levodopa-responsive parkinsonism-dystonia due to a traumatic injury of the substantia nigra].
    Pérez Errazquin F, Gomez Heredia MJ.
    Neurologia; 2012 Apr 15; 27(3):181-3. PubMed ID: 21570743
    [No Abstract] [Full Text] [Related]

  • 15. Effect of histamine H2 receptor antagonism on levodopa-induced dyskinesia in the MPTP-macaque model of Parkinson's disease.
    Johnston TH, van der Meij A, Brotchie JM, Fox SH.
    Mov Disord; 2010 Jul 30; 25(10):1379-90. PubMed ID: 20310030
    [Abstract] [Full Text] [Related]

  • 16. Levodopa-induced dyskinesia in a patient who has normal presynaptic dopaminergic neurons.
    Sunwoo MK, Kim KM, Hong JY, Sohn YH, Lee PH.
    Mov Disord; 2013 Jul 30; 28(8):1152-3. PubMed ID: 23386570
    [No Abstract] [Full Text] [Related]

  • 17. Parkinsonism with multiple cysts in the bilateral striata.
    Norimoto K, Kiuchi K, Morikawa M, Inoue Y, Kosaka J, Inoue M, Kishimoto T.
    Psychogeriatrics; 2011 Sep 30; 11(3):166-70. PubMed ID: 21951957
    [Abstract] [Full Text] [Related]

  • 18. Successful antiparkinsonian medication withdrawal in patients with Parkinsonism and normal FP-CIT SPECT.
    Marshall VL, Patterson J, Hadley DM, Grosset KA, Grosset DG.
    Mov Disord; 2006 Dec 30; 21(12):2247-50. PubMed ID: 17078059
    [Abstract] [Full Text] [Related]

  • 19. SPG11-related parkinsonism: Clinical profile, molecular imaging and l-dopa response.
    Faber I, Martinez ARM, Martins CR, Maia ML, Souza JP, Lourenço CM, Marques W, Montecchiani C, Orlacchio A, Pedroso JL, Barsottini OGP, Ramos CD, Lopes-Cendes Í, Friedman JH, Amorim BJ, França MC.
    Mov Disord; 2018 Oct 30; 33(10):1650-1656. PubMed ID: 30306626
    [Abstract] [Full Text] [Related]

  • 20. Spinocerebellar ataxia type 2 with Levodopa-responsive parkinsonism culminating in motor neuron disease.
    Infante J, Berciano J, Volpini V, Corral J, Polo JM, Pascual J, Combarros O.
    Mov Disord; 2004 Jul 30; 19(7):848-852. PubMed ID: 15254952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.